148 related articles for article (PubMed ID: 23422030)
1. Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma.
Krawczyk M; Höblinger A; Mihalache F; Grünhage F; Acalovschi M; Lammert F; Zimmer V
Dig Liver Dis; 2013 Jul; 45(7):612-5. PubMed ID: 23422030
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
Srivastava B; Mells GF; Cordell HJ; Muriithi A; Brown M; Ellinghaus E; Franke A; ; Karlsen TH; Sandford RN; Alexander GJ; Chapman RW; Rushbrook SM; Melum E
Scand J Gastroenterol; 2012 Jul; 47(7):820-6. PubMed ID: 22554193
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Lin J; Cummings OW; Greenson JK; House MG; Liu X; Nalbantoglu I; Pai R; Davidson DD; Reuss SA
Scand J Gastroenterol; 2015 Apr; 50(4):447-53. PubMed ID: 25635498
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
8. An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.
Melum E; Karlsen TH; Bergquist A; Schrumpf E; Boberg KM
Am J Gastroenterol; 2008 Apr; 103(4):1045; author reply 1045-6. PubMed ID: 18397431
[No Abstract] [Full Text] [Related]
9. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
10. A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large European cohort.
Mihalache F; Hoblinger A; Acalovschi M; Sauerbruch T; Lammert F; Zimmer V
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):412-7. PubMed ID: 22893469
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease.
Häuser F; Deyle C; Berard D; Neukirch C; Glowacki C; Bickmann JK; Wenzel JJ; Lackner KJ; Rossmann H
Genes Immun; 2012 Jun; 13(4):321-7. PubMed ID: 22237417
[TBL] [Abstract][Full Text] [Related]
12. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moreno Luna LE; Gores GJ
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S15-9. PubMed ID: 17051561
[No Abstract] [Full Text] [Related]
13. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
Lazaridis KN
Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
[No Abstract] [Full Text] [Related]
14. Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities.
Goeppert B; Folseraas T; Roessler S; Kloor M; Volckmar AL; Endris V; Buchhalter I; Stenzinger A; Grzyb K; Grimsrud MM; Gornicka B; von Seth E; Reynolds GM; Franke A; Gotthardt DN; Mehrabi A; Cheung A; Verheij J; Arola J; Mäkisalo H; Eide TJ; Weidemann S; Cheville JC; Mazza G; Hirschfield GM; Ponsioen CY; Bergquist A; Milkiewicz P; Lazaridis KN; Schramm C; Manns MP; Färkkilä M; Vogel A; ; Boberg KM; Schirmacher P; Karlsen TH
Hepatology; 2020 Oct; 72(4):1253-1266. PubMed ID: 31925805
[TBL] [Abstract][Full Text] [Related]
15. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
16. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.
Yang Y; Wang J; Wan J; Cheng Q; Cheng Z; Zhou X; Wang O; Shi K; Wang L; Wang B; Zhu X; Chen J; Feng D; Liu Y; Jahan-Mihan Y; Haddock AN; Edenfield BH; Peng G; Hohenstein JD; McCabe CE; O'Brien DR; Wang C; Ilyas SI; Jiang L; Torbenson MS; Wang H; Nakhleh RE; Shi X; Wang Y; Bi Y; Gores GJ; Patel T; Ji B
J Hepatol; 2024 Jul; 81(1):120-134. PubMed ID: 38428643
[TBL] [Abstract][Full Text] [Related]
17. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
18. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.
Rungsakulkij N; Sornmayura P; Tannaphai P
BMC Surg; 2017 Feb; 17(1):17. PubMed ID: 28202062
[TBL] [Abstract][Full Text] [Related]
19. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma.
Chung DT; Tang CN; Lai EC; Yang GP; Li MK
Hong Kong Med J; 2010 Apr; 16(2):149-52. PubMed ID: 20354252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
